ABEO
Abeona Therapeutics Inc.
$6.31
-0.09 (-1.41%)
At close · Jul 6
Market Cap
$359.64M
Shares
56,995,144
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-12 | — | |
| 8-K | 2026-06-12 | 2026-06-11 | |
| 8-K | 2026-06-10 | — | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| DEF 14A | 2026-04-27 | — | |
| 8-K | 2026-04-07 | 2026-04-01 | |
| 8-K | 2026-03-20 | 2026-03-16 | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-03-17 | 2025-12-31 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-18 | — | |
| 8-K | 2025-07-02 | 2025-06-27 | |
| 8-K | 2025-05-19 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-05-12 | 2025-05-09 | |
| 8-K | 2025-04-29 | — | |
| 8-K | 2025-04-29 | — | |
| DEF 14A | 2025-04-09 | 2024-12-31 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2024-12-20 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-12 | 2024-11-08 | |
| DEF 14A | 2024-11-12 | — | |
| 8-K | 2024-10-29 | 2024-10-28 | |
| 8-K | 2024-08-14 | 2024-08-08 | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-07-09 | 2024-07-05 | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-03 | — | |
| 8-K | 2024-05-03 | 2024-05-02 | |
| 8-K | 2024-04-24 | — | |
| 8-K | 2024-04-22 | — | |
| DEF 14A | 2024-03-19 | — | |
| 10-K | 2024-03-18 | 2023-12-31 | |
| 8-K | 2024-03-18 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-27 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 |
Showing 1–50 of 135 filings